Cited by

• HLA-DP does not contribute towards susceptibility to systemic lupus erythematosus.

  Davies EJ, Hutchings CJ, Hillarby MC, Donn RP, Cooper RG, Hay EM, Bernstein RM, Holt PJ, Grennan DM, Ollier WE. Davies EJ, et al. Ann Rheum Dis. 1994 Mar;53(3):188-90. doi: 10.1136/ard.53.3.188. Ann Rheum Dis. 1994. PMID: 8154937 Free PMC article.
• The genetics of systemic sclerosis.

  Johnson RW, Tew MB, Arnett FC. Johnson RW, et al. Curr Rheumatol Rep. 2002 Apr;4(2):99-107. doi: 10.1007/s11926-002-0004-2. Curr Rheumatol Rep. 2002. PMID: 11890874 Review.
• No direct correlation between HLA-DPB1 and antibodies against recombinant Ro (SS-A)/La (SS-B) proteins in systemic lupus erythematosus. SLE Study Group.

  Yao Z, Hartung K, Ehrfeld H, Seelig HP, Deicher HG, Brünnler G, Keller E, Albert E. Yao Z, et al. Rheumatol Int. 1993;13(4):155-8. doi: 10.1007/BF00301263. Rheumatol Int. 1993. PMID: 8310208
• HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans.

  Zhou X, Lee JE, Arnett FC, Xiong M, Park MY, Yoo YK, Shin ES, Reveille JD, Mayes MD, Kim JH, Song R, Choi JY, Park JA, Lee YJ, Lee EY, Song YW, Lee EB. Zhou X, et al. Arthritis Rheum. 2009 Dec;60(12):3807-14. doi: 10.1002/art.24982. Arthritis Rheum. 2009. PMID: 19950302 Free PMC article.
• HLA antigens in Malay patients with systemic lupus erythematosus: association with clinical and autoantibody expression.

  Azizah MR, Ainol SS, Kong NC, Normaznah Y, Rahim MN. Azizah MR, et al. Korean J Intern Med. 2001 Jun;16(2):123-31. doi: 10.3904/kjim.2001.16.2.123. Korean J Intern Med. 2001. PMID: 11590899 Free PMC article. Clinical Trial.